Daily Archives: March 1, 2014


The Department of Justice announced that it intervened and reached a settlement in the Endo Pharmaceuticals Inc. Qui Tam Whistleblower lawsuit. The civil liability in the Endo Pharmaceuticals Qui Tam Whistleblower lawsuit involved Endo’s marketing of the prescription drug Lidoderm for uses not approved as safe and effective by the […]

Endo Pharmaceuticals Qui Tam Whistleblower lawsuit